Efficacy and Safety of Oral Semaglutide in Patients With Type 2 Diabetes and Moderate Renal Impairment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Oral Semaglutide in Patients With Type 2 Diabetes and Moderate Renal Impairment (PIONEER 5): A Placebo-Controlled, Randomised, Phase 3a Trial
Lancet Diabetes Endocrinol 2019 Jun 06;[EPub Ahead of Print], O Mosenzon, TM Blicher, S Rosenlund, JW Eriksson, S Heller, OH Hels, R Pratley, T Sathyapalan, C DesouzaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.